CSF1R and neoplasm: It is important to highlight that the tumor growth reduced more than 90% when CSF1R blockade was combined with either anti-CTLA-4 or anti-PD-1 compared to the mice treated only with anti-CTLA-4 or anti-PD-1 alone.